TOKYO (Reuters) - The Japanese government will soon agree a supply deal for more than 100 million doses of a coronavirus vaccine being developed by AstraZeneca Plc
The British drugmaker has been in talks with Japan, Russia, Brazil and others about supply deals for its potential coronavirus vaccine, known as AZD1222.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.